Understanding health technology assessment.
To make the best use of scarce national health-care resources the adoption and diffusion of new technologies is now linked to evidence of their cost- as well as clinical effectiveness. Thus, the goal of medical device manufacturers today must be to provide value for money. This article details the process of conducting this assessment.
Craig
A M
AM
The Lewin Group, Quintile Scotland Limited, Heriot-Watt University Research Park, Edinburgh, UK. amcraig@quintiles.com
D003362:Cost-Benefit Analysis; D005060:Europe; D013673:Technology Assessment, Biomedical / Q000191:economics / Q000458:organization & administration